Key result
Synthetic LDL stimulates U937 cell proliferation, mimicking native LDL via LDL receptor pathways.
Why the study?
The biological properties and receptor interactions of synthetic LDL particles were investigated to develop a viable large-scale sLDL production method for research applications.
Does not support clinical use; extends in vitro tools for LDL receptor studies.
A synthetic LDL (sLDL) has been prepared by combining a lipid microemulsion with amphipathic peptides containing the apoprotein B receptor domain. The biological properties of sLDL have been investigated using the U937 in vitro cell proliferation assay. sLDL exhibits a concentration dependent and saturable stimulation of U937 proliferation. By utilizing different amphipathic peptides, variable proliferation is achieved, indicating a specific interaction between sLDL and the U937 LDL receptor are possible. U937 proliferation is reduced by the addition of an anti-LDL receptor antibody, indicating that sLDL is assimilated via the LDL receptor pathway. The behavior of sLDL mimics that of native LDL, and this approach represents a viable technique for the production of an sLDL particle on a large scale for research and general application. —Baillie, G., M. D. Owens, and G. W. Halbert. A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro. J. Lipid Res. 2002. 43: 69–73.
No takes yet. Share an insight, caveat, or question.
Baillie et al. (2002) studied this question. Synthetic LDL (sLDL) vs. Native LDL was evaluated on U937 in vitro cell proliferation. Synthetic LDL stimulated U937 cell proliferation in a concentration-dependent and saturable manner, mimicking native LDL behavior via the LDL receptor pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: